E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/7/2005 in the Prospect News Convertibles Daily.

Convertibles Calendar

FEB. 7 WEEK

HUNTSMAN CORP.: $250 million of three-year mandatory convertibles, with $37.5 million greenshoe; price talk of 5.0% to 5.5% dividend, 18% to 22% initial conversion premium; concurrent with initial public offering of 55.681 million shares of common stock in estimated price range of $21 to $23 a share, estimated to fetch $1.3 billion; $50 par; issue to have provisional call with 140% threshold; $40 million in proceeds will be used to buy Treasuries as collateral for dividends on the convert; Salt Lake City chemical company plans to use $591.3 million of proceeds to redeem HMP Equity Holdings Corp.'s 15% senior secured discount notes due 2008, $486.6 million to redeem Huntsman International Holdings LLC's 13.375% senior discount notes due 2009, $177.9 million to repay the $159.4 million principal amount of Huntsman LLC's 11.625% senior secured notes due 2010, repay in full Huntsman LLC's 15% subordinated note to Horizon Ventures LLC that matures in 2011, and any remaining proceeds to repay any remaining amount due on the Huntsman International senior discount notes; convertible bookrunners will be Citigroup Global Markets Inc., Credit Suisse First Boston, Merrill Lynch and Deutsche Bank Securities; pricing week of Feb. 7.

PROTEIN DESIGN LABS INC. (Symbol: PDLI): Rule 144A; $250 million of seven-year senior unsecured convertible notes; $50 million greenshoe; price talk of a 1.25% to 1.75% coupon, 30% to 35% initial conversion premium; non-callable for five years; dividend protection via a conversion ratio adjustment; Fremont, Calif.-based biotech concern to use proceeds for working capital and other general corporate purposes, including research and development, capital expenditures and expansion of manufacturing facilities - also said it may use a portion of proceeds to pay for the proposed $500 million acquisitions of ESP Pharma Holding Co. Inc. and the drug product Retavase, and to acquire or invest in other complementary businesses, products or technologies; sole bookrunner is Goldman Sachs & Co.; pricing slated for after the market close Tuesday.

SOUTHERN UNION CO. (Symbol: SUG): Registered; $100 million of three-year mandatory convertible preferreds; par $50; dividend protection via a conversion ratio adjustment; price talk of 5.0% to 5.5% dividend, 20% to 25% initial conversion premium; Wilkes-Barre, Pa.-based natural gas pipeline operator to use proceeds to repay debt incurred in connection with its investment in CCE Holdings LLC.; joint bookrunners are JPMorgan Securities and Merrill Lynch; pricing slated after the market close Wednesday.

ON THE HORIZON

PNM RESOURCES INC. (Symbol: PNM): $200 million of equity-linked securities as part of financing package for $1.024 billion acquisition of TNP Enterprises Inc.; timing to coincide with acquisition closing 9 to 12 months from announcement on July 25; letter of intent obtained for the purchase of $100 million of the equity-linked securities from an existing shareholder; Albuquerque, N.M., electric utility also plans to issue $250 million of common equity, of which $95 million will go to TNP Enterprises shareholders, and place $100 million of long-term senior notes; expected ratings BBB/Baa2.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.